Bitnomial launches Injective futures in US, with eyes on ETF eligibility
The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.
Why this matters
This maps to the Market Structure hub, so it can help confirm whether that theme is gaining breadth across the crypto news cycle.
Original source
Read on CointelegraphRelated market context
IMF Flags $300T Tokenization Gap, Warns 24/7 Markets Could Amplify Market Risks
Key Takeaways: About $300 billion – $350 billion are traded in tokenized repos every day, which remains significantly smaller than...
XRP News: Ripple Challenges Wall Street for a Slice of $256B ETF Market
The U.S. leveraged ETF market has 593 funds and more than $256 billion in assets, including XRP, and Ripple Prime is making itself...
OSL Brings A USDGO Market-Neutral Fund On-Chain For Hong Kong Investors
TL;DR: OSL Group has tokenized the USDGO Plus SP fund on-chain and is providing custody and distribution through its licensed Hong...
Sui’s Hashi Bitcoin Finance Network Launches With More Than $500 Million Committed
TL;DR: Hashi, Sui’s native Bitcoin finance infrastructure, will begin a phased mainnet rollout later this month with more than $50...
Bitcoin’s slide below $81,000 exposes why a Fed pause may not save the crypto market
Bitcoin slid below $81,000 on Oct. 8, with an intraday low near $80,800, even as traders expect the Fed to hold in October. The Se...
Bitcoin Price Prediction: Is the US Government Behind The Crypto Crash?
Bitcoin is trading at $82,400 after losing 4% over the past week, but that bounce does little to settle the question behind the se...